L. Brugiéres

1.1k total citations
28 papers, 789 citations indexed

About

L. Brugiéres is a scholar working on Oncology, Neurology and Molecular Biology. According to data from OpenAlex, L. Brugiéres has authored 28 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Neurology and 6 papers in Molecular Biology. Recurrent topics in L. Brugiéres's work include Neuroblastoma Research and Treatments (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). L. Brugiéres is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). L. Brugiéres collaborates with scholars based in France, United Kingdom and United States. L. Brugiéres's co-authors include J Lemerle, Gilles Vassal, E Benhamou, D Valteau, Dominique Valteau‐Couanet, Olivier Hartmann, Oliver Hartmann, C Kalifa, Valérie Méresse and Dominique Challine and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and European Journal of Cancer.

In The Last Decade

L. Brugiéres

25 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Brugiéres France 12 265 244 181 172 149 28 789
O Hartmann France 16 167 0.6× 185 0.8× 203 1.1× 61 0.4× 137 0.9× 40 668
Ronald L. Chard United States 17 185 0.7× 445 1.8× 151 0.8× 110 0.6× 103 0.7× 26 904
J Akatsuka Japan 14 112 0.4× 403 1.7× 124 0.7× 74 0.4× 98 0.7× 43 734
Walter Longo United States 15 387 1.5× 254 1.0× 65 0.4× 154 0.9× 121 0.8× 62 843
Hassan El‐Solh Saudi Arabia 15 226 0.9× 169 0.7× 71 0.4× 97 0.6× 83 0.6× 40 693
Emiko Sakaida Japan 17 186 0.7× 373 1.5× 160 0.9× 149 0.9× 143 1.0× 103 866
Germán A. Gómez United States 16 136 0.5× 402 1.6× 106 0.6× 380 2.2× 158 1.1× 59 903
Nicola Piccirillo Italy 14 176 0.7× 330 1.4× 53 0.3× 184 1.1× 66 0.4× 67 715
Hyery Kim South Korea 16 152 0.6× 198 0.8× 61 0.3× 104 0.6× 74 0.5× 100 665
Maurizio Miano Italy 19 137 0.5× 620 2.5× 93 0.5× 146 0.8× 67 0.4× 68 1.1k

Countries citing papers authored by L. Brugiéres

Since Specialization
Citations

This map shows the geographic impact of L. Brugiéres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Brugiéres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Brugiéres more than expected).

Fields of papers citing papers by L. Brugiéres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Brugiéres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Brugiéres. The network helps show where L. Brugiéres may publish in the future.

Co-authorship network of co-authors of L. Brugiéres

This figure shows the co-authorship network connecting the top 25 collaborators of L. Brugiéres. A scholar is included among the top collaborators of L. Brugiéres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Brugiéres. L. Brugiéres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taque, Sophie, Guillaume Morcrette, L. Brugiéres, et al.. (2021). Hepatoblastoma en el niño. 56(1). 1–10.
2.
Kelly, Kara M., Stephen Daw, Christine Mauz‐Körholz, et al.. (2019). RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES. Hematological Oncology. 37(S2). 56–57. 3 indexed citations
3.
Haddy, Nadia, Laurence Tartier, Élisabeth Adjadj, et al.. (2014). Repair of ionizing radiation-induced DNA damage and risk of second cancer in childhood cancer survivors. Carcinogenesis. 35(8). 1745–1749. 16 indexed citations
4.
Woessmann, Willi, L. Brugiéres, A Rosolen, et al.. (2012). Risk-adapted therapy for patients with relapsed or refractory ALCL - interim-results of the prospective EICNHL-Trial ALCL-relapse. British Journal of Haematology. 159. 41–41. 4 indexed citations
5.
Semeraro, Michaëla, Sophie Branchereau, Rudolf Maibach, et al.. (2012). Relapses in hepatoblastoma patients: Clinical characteristics and outcome – Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). European Journal of Cancer. 49(4). 915–922. 75 indexed citations
6.
Guérin, Sabrina, Mary E. Hawkins, A. Shamsaldin, et al.. (2007). Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: A case-control study. Journal of Clinical Oncology. 25(18_suppl). 21031–21031.
7.
Perilongo, Giorgio, E. Shafford, L. Brugiéres, et al.. (2003). 717 Risk adapted treatment for childhood hepatoblastoma (HB): final report of the second study of the International Society of Paediatric Oncology SIOPEL' 2. European Journal of Cancer Supplements. 1(5). S216–S217.
8.
Brugiéres, L., et al.. (2000). HEPATOBLASTOMA – MICROSCOPICAL RESIDUAL DISEASE AFTER DELAYED SURGERY: PROGNOSTIC IMPLICATIONS. 177–177. 4 indexed citations
9.
Bouché, Olivier, et al.. (1997). Myocardiopathie dilatée aux catécholamines dans le neuroblastome. Archives de Pédiatrie. 4(1). 32–35. 10 indexed citations
10.
Kony, Sabine, Florent de Vathaire, Emmanuel Grimaud, et al.. (1997). Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. The Lancet. 350(9071). 91–95. 104 indexed citations
11.
Bihan-Benjamin, Christine Le, Céline Moutou, Anne S. Abel, et al.. (1996). Cancers in relatives of children with non-Hodgkin's lymphoma. Leukemia Research. 20(2). 181–186. 10 indexed citations
12.
Pein, F, Olivier Hartmann, C Bayle, et al.. (1995). Recherche d'un envahissement de la moelle osseuse lors du diagnostic de tumeur solide chez l'enfant. Méthodes, résultats et interprétation. Archives de Pédiatrie. 2(6). 580–588. 1 indexed citations
13.
Grill, Jacques, et al.. (1994). [Humoral immunity and infections during bone marrow transplantation in children: study of 127 transplanted patients successively in a same center].. PubMed. 1(5). 463–9. 3 indexed citations
14.
Hartmann, Oliver, et al.. (1993). Systemic Candida infection in pediatric BM autotransplantation: clinical signs, outcome and prognosis.. PubMed. 11(6). 465–70. 15 indexed citations
15.
Méresse, Valérie, Olivier Hartmann, Gilles Vassal, et al.. (1992). Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.. PubMed. 10(2). 135–41. 110 indexed citations
16.
Hartmann, Oliver, et al.. (1990). [Neonatal Pepper's syndrome. Apropos of a series of 22 cases].. PubMed. 47(2). 91–6. 2 indexed citations
17.
Hartmann, Olivier, O. Oberlin, F Beaujean, et al.. (1990). [Role of high-dose chemotherapy followed by bone marrow autograft in the treatment of metastatic Ewing's sarcoma in children].. Bulletin du Cancer. 77(2). 181–7. 21 indexed citations
18.
Vassal, Gilles, Alain Deroussent, Oliver Hartmann, et al.. (1990). Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study.. PubMed. 50(19). 6203–7. 140 indexed citations
19.
Brugiéres, L., Olivier Hartmann, J P Travagli, et al.. (1989). Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome.. Journal of Clinical Oncology. 7(2). 194–199. 82 indexed citations
20.
Brugiéres, L., D Valteau, Catherine Patte, et al.. (1989). [Malignant histiocytosis in children. Clinical and therapeutic aspects. Apropos of a series of 32 cases].. PubMed. 36(8). 493–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O Hartmann Breakdown of academic impact, for papers by Ronald L. Chard Breakdown of academic impact, for papers by J Akatsuka Breakdown of academic impact, for papers by Walter Longo Breakdown of academic impact, for papers by Hassan El‐Solh Breakdown of academic impact, for papers by Emiko Sakaida Breakdown of academic impact, for papers by Germán A. Gómez Breakdown of academic impact, for papers by Nicola Piccirillo Breakdown of academic impact, for papers by Hyery Kim Breakdown of academic impact, for papers by Maurizio Miano
Rankless by CCL
2026